Category Archives: Industry: Healthcare

Healthcare is an ever evolving industry, and field. These Press Releases, will keep you up to date on the newest, greatest, best, solutions available.

Family Building through Surrogacy and IVF, Hosted by SGF New York, Circle Surrogacy & Egg Donation, and Fly Bravely


For women and men exploring IVF and surrogacy to grow their family, SGF New York, Circle Surrogacy & Egg Donation, and Fly Bravely will be hosting a free, anonymous virtual panel discussion.

For men and women thinking about their future family, or those ready to start taking steps toward surrogacy and IVF, this virtual informational session will provide answers.

Last month, New York State passed a key piece of legislation, the Child-Parent Security Act, establishing and protecting the rights of surrogates and intended parents pursuing surrogacy journeys in NY state. This change allows those struggling with infertility, cancer survivors, as well as the LGBTQ community to have the opportunity to build their families with the assistance of a gestational carrier (GC) in their home state.

For women and men exploring IVF and surrogacy to grow their family, Shady Grove Fertility (SGF) New York, Circle Surrogacy & Egg Donation, and Fly Bravely will be hosting a free, anonymous virtual panel discussion on May 14, 2020, at 6 PM.

Attendees will hear from three women with three very different stories who grew their families through surrogacy and IVF. Each will share their journeys to motherhood—how the process started, what brought them to surrogacy, and where they are now.

Plus, attendees will hear from experts from SGF New York, Circle Surrogacy & Egg Donation, and Fly Bravely about the IVF and surrogacy process, costs, and more.

Hear from Mothers about their Surrogacy and IVF Experience:


  • Lia Buffa De Feo, Founder of Fly Bravely—a New York City consultancy dedicated to destigmatizing infertility and raising awareness of infant loss by providing information, hope, support and advocacy to New Yorkers who experience difficulty on their family-building journey.
  • Cynara Charles-Pierre who became a mother via surrogacy after eight miscarriages and was a key player in advocacy efforts that resulted in passage of the Child-Parent Security Act.
  • Angela Salerni, a cancer survivor and a mother via surrogacy.

Surrogacy and IVF Expert Panel to Provide Guidance on Process, Cost, Legalities, and More:

  • Anate Brauer, M.D., FACOG: Board-certified reproductive endocrinologist with extensive experience in treating all medical and surgical aspects of infertility. Dr. Brauer serves as SGF’s New York’s IVF Director. SGF is home to the largest donor egg treatment program in the nation.
  • Sam Hyde, President of Circle Surrogacy & Egg Donation.
  • Dean Hutchison, Esq: Vice President of Legal Services at Circle Surrogacy & Egg Donation, and Chairman of the American Bar Association’s Committee on Assisted Reproductive Technology Law.
  • Jen Rachman, LCSW: Licensed Clinical Social Worker and Outreach Associate at Circle Surrogacy & Egg Donation. Jen is also a New York parent through surrogacy.

For men and women thinking about their future family, or those ready to start taking steps toward surrogacy and IVF, this virtual informational session will provide answers.

To register for this complimentary event, click here.

About Shady Grove Fertility (SGF)

SGF is a leading fertility and IVF center of excellence with more than 85,000 babies born and counting. With 38 locations throughout FL, GA, MD, NY, PA, VA, D.C., and Santiago, Chile, we offer patients virtual physician consults, individualized care, accept most insurance plans, and make treatment affordable through innovative financial options, including treatment guarantees. More physicians refer their patients to SGF than any other center. Call 1-888-761-1967 or visit ShadyGroveFertility.com.

About Circle Surrogacy & Egg Donation

Family is our inspiration. With almost 25 years of experience and almost 2,000 babies born, Circle Surrogacy is one of the oldest and most successful full-service surrogate parenting agencies in the world. Our dedicated staff is comprised of social workers, attorneys, program coordinators, accountants, experienced and former surrogates, egg donors and parents through our program. We have achieved unparalleled success rates for our intended parents by controlling costs, managing insurance, securing high-quality IVF treatment, and focusing on our matching process. We offer complimentary consultations as well as informational seminars over Skype, in our office, and in many major cities around the world.

About Fly Bravely

Fly Bravely is a New York City consultancy dedicated to destigmatizing infertility and raising awareness of infant loss by providing information, hope, support and advocacy to New Yorkers who experience difficulty on their family-building journey. As a catalyst for change, we create discourse and establish policies to help people move forward bravely while enduring challenging paths to parenthood.

Share article on social media or email:

Bizmatics Launches Standalone Telehealth Product, Virtual Md, to further Expand Access to Virtual Care for Providers and Patients


Bizmatics Inc, a Silicon Valley-based, Healthcare IT company, and the leaders in Ambulatory EHR and Telemedicine Software, today announced the launch of their Standalone telehealth solution, Virtual Md. Their free-standing telehealth solution focuses on filling the gaps in healthcare delivery for small, medium, large, and multi-specialty practices.

Virtual Md, delivers a proven, secure, and HIPAA compliant alternative to current market offerings. Through its state of the art digital technology, Bizmatics is successfully supporting thousands of Provider and Patient encounters daily. Bizmatics brings nearly twenty years of expertise in healthcare management and is currently serving the needs of a multitude of medical practices.

Virtual Md, a robust telemedicine platform, is designed for flexibility – it works independently, or integrates easily with an existing EHR, Practice Management system using HL7 connectivity or CCD. This comprehensive standalone alternative presents a cost-effective, stable solution, allowing providers to register patients, schedule appointments, conduct video conferencing sessions, and document notes efficiently.

“Virtual Md is designed to be the First-Line in healthcare consultation. We have seen that Healthcare delivery has undergone significant changes during the recent COVID-19 Pandemic. Telemedicine, in particular, has seen a sharp increase in usage, Virtual Medical Visits will now become the norm for patient care” says Vinay Deshpande, CEO of Bizmatics, Inc. “We believe that more patients will embrace telehealth as they start becoming accustomed to using this easy and convenient healthcare platform. Virtual Md telehealth is built to deliver a great user experience from both, the patient and providers perspective”, he further added.

The workflows are designed for providing overall patient care including initial patient consultations, routine check-ups, chronic care management and follow up visits.

Releasing at a time when communities across the US are relying on telehealth to tackle COVID-19 pandemic, Virtual Md will further expand the availability of care to numerous medical practices, nursing homes, rural healthcare centers, and more.

About Bizmatics Inc : Bizmatics is a healthcare technology company serving the needs of Ambulatory Medical Practices of all sizes and specialties. PrognoCIS – their cloud-based EHR streamlines workflows through a platform of stable and mature modules and features which includes Practice Management, Medical Billing, Revenue Cycle Management, Telemedicine, Patient Portal, and e-prescription. PrognoCIS EHR delivers a customizable, tailor-made workflow with rich and specialty-specific content for medical clinics and hospitals.

For further information on PrognoCIS EHR, visit: https://prognocis.com/

Share article on social media or email:

AltaPointe recognizes Children’s Mental Health Awareness Week 2020


Children’s Mental Health Awareness Week banner created by a child enrolled in an AltaPointe program.

Children’s Mental Health Awareness Week (CMHAW) is underway across AltaPointe Health’s continuum. Every year the first full week of May is set aside to raise awareness about children’s mental health and the programs available to treat the youngest of patients. The National Alliance on Mental Illness (NAMI) reports 1 in 5 children 13 to 18 years of age have, or will have a serious mental illness.

During this unsettling time, mental health experts expect to see an increase in calls for access to care when compared to the same period last year. Fear of becoming sick, family stress, and how long the pandemic will last will have people seeking help who never needed mental health support before, including children.

Children’s mental health is a priority for AltaPointe Health. In 2019, more than 11,000 children were treated at an AltaPointe program. AltaPointe has a full continuum of care devoted to children, including; outreach, outpatient, residential services, hospital services, and school-based therapy. AltaPointe’s school-based therapy program reaches students in schools across Mobile, Baldwin, and Washington counties, as well as schools in Clay, Coosa, and Talladega counties.

NAMI says 50 percent of all lifetime cases of mental illness begin by age 14. The average delay between the first signs of illness and treatment is 8 to 10 years. Experts agree the sooner you seek treatment, the higher your chance for recovery.

AltaPointe wants to help you understand what’s normal, what’s not, and what’s next when it comes to your child’s behavior. You can tune in to AltaPointe Health’s Facebook page for a live event on Friday, May 8, at 1 p.m. to hear from the experts.

Eddie Pratt, therapist and coordinator of AltaPointe’s day treatment services in Baldwin County, along with Nicolette Harvey, Licensed Independent Clinical Social Worker and assistant director of BayPointe Children’s Hospital, will answer your questions and help you recognize when you may need to seek professional mental health help for your child or adolescent. BayPointe provided 117,319 psychiatric services in 2019.

AltaPointe strives to be a provider of choice in health and specialty services for people of all ages living in the Mobile Bay region and east-central Alabama. Using specialized training, best clinical practices, and innovative technology, we work to provide the best care possible in our outpatient, residential, psychiatric hospitals, and primary care settings. AltaPointe offers services to residents living in Baldwin, Clay, Coosa, Mobile, Talladega, Randolph, and Washington counties. It employs 1,550 people and serves 35,000 individuals annually. It is Alabama’s most comprehensive health and human services organization.

Share article on social media or email:

Cornell Dubilier Introduces Type Q, Defibrillator Capacitors Which Offer High Energy Density, and are Available in Multiple Packaging Options


Cornell Dubilier’s Type Q Defibrillator Capacitors

Cornell Dubilier Electronics, Inc. announces the availability of its Q Series film capacitors for medical defibrillator applications. Designed specifically for today’s quick response and professional use defibrillators, the Q Series meets the reliability demands of Class III medical devices. Used extensively in automated external defibrillators (AEDs), the series offers designers the highest in-class energy density and broadest range of packaging options.

Q Series capacitors are designed for use in monophasic and bi-phasic defibrillators with energy densities as high as 2 J/cc. Some designs can deliver in excess of 500 joules when fully charged. Voltage ratings range from 800 Vdc to 6,000 Vdc with capacitance values covering the range from 32 to 500 μF.

Standard packages include oil-filled metal cases or epoxy-filled plastic cases, both available in either round or oval configurations. A multitude of terminations are available ranging from quick-connect blades to insulated wire leads. The company also has the capability of integrating capacitor windings into a custom molded package to achieve the smallest possible profile and highest energy density for the end-device.

Over the past 20 years CDE’s engineers have advanced the metallized film capacitor technology, processing and testing to help its customers achieve the smallest and most reliable designs. With the capability of withstanding 40,000 charge/discharge cycles (depending on part and application),Q Series capacitors are designed for long-term reliable service where it matters the most.

For inquiries, contact: Tim Flaherty (tflaherty@cde.com), Business Development Manager For more information on these Series visit: https://cde.com/new-product/type-q

###

Note to Editors: Since its founding in 1909, CDE has been dedicated to advancing capacitor technology for new applications. The company combines innovative products with engineering expertise to provide reliable component solutions for inverters, wind and solar power, electric vehicles, power supplies, motor drives, HVAC, motors, welding, aerospace, telecom, medical equipment and UPS systems. A global company, Cornell Dubilier has ISO-9001 certified manufacturing and distribution facilities in Liberty, SC; New Bedford, MA; Mexicali, Mexico; and Hong Kong.

Share article on social media or email:

The Karis Group Announces New President & CEO to Support Future Growth


I see a unique opportunity for Karis to expand in a way that offers our clients personally relevant solutions driven by innovative technology and a world class user experience. I’m excited to lead Karis as CEO and for the whole team to continue to make this a great company.

The Karis Group, an award-winning health navigation and bill negotiation company in Austin, TX, announced today the promotion of Matt Dale to President and Chief Executive Officer. The Karis Group is pleased to have someone who has been part of the team for many years and most recently served as Vice President of Strategic Initiatives evolve into the role of CEO and lead the company into its next chapter of growth.

Mr. Dale will lead The Karis Group’s cost containment efforts through their innovative fair pricing medical negotiation offerings, and healthcare navigation services directing patients to the right care at the best price.

“My son, Matt Dale, has been with Karis from its earliest days,” said Dr. Tony Dale, Founder and Board Chair. “As a teenager helping with data entry, when the company was really just me working from home, right through his active involvement in every major initiative and spin off of other companies over the past decade. His insights as VP of Strategic Initiatives have shaped the company and prepared him well for now taking over the vision and leadership of Karis in these rapidly changing times.”

Matt Dale added, “I see a unique opportunity for Karis to expand in a way that offers our clients personally relevant solutions driven by innovative technology and a world class user experience. I’m excited to lead Karis as CEO and for the whole team to continue to make this a great company.”

Mr. Dale replaces Kim Evans, who helped over the past 16 months to set the foundation for The Karis Group’s future growth. The Karis Group is focused on placing quality healthcare within reach of all who need it by delivering an improved healthcare experience to their members.

About The Karis Group

The Karis Group, Inc. is an Austin, Texas-based company founded in 1996. The organization is a leader in providing health navigation and bill negotiation services through its trademarked Karis 360 platform of services that save its customers time, money, and frustration.

Learn more at: http://www.thekarisgroup.com

Share article on social media or email:

Silicon Valley Orthopaedics (SVO) Reintroducing Elective Procedures and Surgeries for Patients


News Image

Our patients’ health is our top priority, and we are looking forward to thoughtfully resuming elective surgeries, stated Kerisimasi Reynolds, MD, co-founder and orthopedic surgeon at Silicon Valley Orthopaedics.

Silicon Valley Orthopaedics will begin to schedule elective procedure visits under specific, strict safety measures. The practice will continue to offer virtual telemedicine visits for patients and urgent emergency orthopedic care for those not experiencing coronavirus symptoms. The SVO team is committed to using safety protocols and remaining vigilant when it comes to sanitation, screening, visitor restrictions, masking, as well as all additional guidelines from the CDC.

The practice has been focusing on planning and prepping to eventually return safely to providing routine patient care services. Silicon Valley Orthopaedics is working diligently to continue to collect as much information from the state as well as government agencies on COVID-19 developments as they become available and will continue to adjust their operations to follow all recommendations being made.

“Our patients’ health is our top priority, and we are looking forward to thoughtfully resuming elective surgeries,” stated Kerisimasi Reynolds, MD, co-founder and orthopedic surgeon at Silicon Valley Orthopaedics. “We will be initiating all the necessary precautions to protect our patients, medical team and community, continuing with our services to the best of our abilities during this time,” added Nic Gay, MD, also a co-founder and orthopedic surgeon at SVO.

More about Silicon Valley Orthopaedics (SVO):

Dr. Nic Gay and Dr. Kerisimasi Reynolds lead Silicon Valley Orthopaedics, helping patients across San Jose and the Silicon Valley area reach their musculoskeletal health goals. SVO is located at 39180 Farwell Dr., Suite 110, in Fremont, CA. This state-of-the-art practice utilizes innovative, evidence-based surgical and non-surgical techniques, focusing on the individual needs of their valued patients. The experienced SVO team will provide an accurate diagnosis and appropriate treatment plans to address joint pain so that patients achieve optimum results. To schedule a virtual appointment or for more information about elective surgery scheduling or other services, please call (650) 379-4616 or visit http://www.siliconvalleyortho.com.

Share article on social media or email:

Forcura Named One of Inc. Magazine’s Best Workplaces for 2020


Forcura logo and Inc. logo

“When employees feel valued and respected, especially during times of crisis, it’s easier for everything else to fall into place.” – Founder and CEO Craig Mandeville

Forcura has been named to Inc. magazine’s annual list of the Best Workplaces for 2020. Hitting newsstands May 12 in the May/June 2020 issue, and as part of a prominent Inc.com feature, the list is the result of a wide-ranging and comprehensive measurement of private American companies that have created exceptional workplaces through vibrant cultures, deep employee engagement, and stellar benefits.

Forcura is a health technology company that gives post-acute providers control over the referral and orders management processes. Our suite of cloud-based tools centralizes and digitizes documents, streamlines workflows, facilitates secure clinical communications, and enables data-driven decisions. Founded in 2012, Forcura currently employs 73 and experienced 70% year-over-year growth in 2019.

Collecting data from more than 3,000 submissions, Inc. singled out 395 finalists for this year’s list. Each nominated company took part in an employee survey, conducted by Quantum Workplace, on topics including trust, management effectiveness, perks, and confidence in the future. Inc. gathered, analyzed, and audited the data. They then ranked all the employers using a composite score of survey results. This year, 73.5 percent of surveyed employees were engaged by their work.

The strongest engagement scores came from companies that prioritize the most human elements of work. These companies are leading the way in employee recognition, performance management, and diversity. It is a different playbook from a decade ago, when too many firms used the same template: free food, open work environments, and artifacts of “fun.”

“We’ve long recognized that culture is the foundation of our corporate success, so much so that we added it as just one of three KPIs on our company scorecard beginning in 2017,” says Forcura’s founder and CEO Craig Mandeville. “I’m proud that we continue to inspire our employees, who are some of the best and brightest talent in the country. When employees feel valued and respected, especially during times of crisis, it’s easier for everything else to fall into place.”

“Building a great corporate culture comes only from strong leadership,” says Inc. magazine editor-in-chief Scott Omelianuk. “The companies on Inc.’s Best Workplaces list are setting an example that the whole country can learn from, especially now, when company culture is more important to the workforce than ever.”

About Forcura

Forcura, a leading healthcare technology company headquartered in Jacksonville, Florida, facilitates continuity of care via technology, analytics and a deep commitment to enabling better patient care. The Forcura suite of tools is powered by Forcura Connect, a proprietary framework for standardizing interoperability and integration among post-acute health care organizations, physicians, electronic health records (EHRs) and other supporting technology vendors. Through our technology and analytics solutions, we are a step closer every day to elevating the opportunities of post-acute care. The company has received awards for Fastest Growing Company for the fourth consecutive year, Best UI/UX Design in SaaS, and Best Places to Work by Inc. Magazine. For more information visit http://www.forcura.com, call 800-378-0596 or follow Forcura on LinkedIn.

About Inc. Media

The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit http://www.inc.com.

About Quantum Workplace

Quantum Workplace, based in Omaha, Nebraska, is an HR technology company that serves organizations through employee-engagement surveys, action-planning tools, exit surveys, peer-to-peer recognition, performance evaluations, goal tracking, and leadership assessment. For more information, visit QuantumWorkplace.com.

Share article on social media or email:

NeoTract Designates Dr. Keith Waguespack as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Keith Waguespack as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Keith Waguespack M.D., Urology Partners of North Texas in Irving, TX, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Waguespack has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Keith Waguespack as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Saisei Pharma plans clinical study of oral MAF in COVID-19 patients


our innate immunity can fight off pathogens without causing inflammation and associated respiratory deterioration

Saisei Pharma today announced plans to initiate an international clinical trial. The decision is based on published preclinical evidence, preliminary reports from independent studies and is supported by data of the safety and efficacy of oral MAF in conditions that require the involvement of macrophages as the front line defense in innate immunity. Prior studies have indicated that oral MAF can activate macrophage activity at least three-fold within a few minutes after application. This outstanding phenomenon could play an important role in deploying rapid innate immune response against SARS-CoV-2. The MAF induced phagocytosis enhances antigen processing and their presentation to effector lymphocytes, which is critical in forming the adequate adaptive immune response and synthesis specific antiviral antibodies [1-4]. Enhanced phagocytosis of SARS-CoV-2 viral particles and quicker effective innate and adaptive immune responses increase the probability of the abortive or shorter infection course. In addition to reduced viral load, MAF can downplay hyperactive proinflammatory response causing respiratory failure.

‘’The efficient innate immune response against SARS-CoV-2 is critical since there is no pre-existing immunity to exotic coronaviruses in humans who were not exposed to it earlier. The potent effect of Saisei Pharma MAF on phagocytosis is not accompanied by clinical or biochemical signs of inflammation when administered to humans. This means that our innate immunity can fight off pathogens without causing inflammation and associated respiratory deterioration” said immunologist Dr. Galyna Kutsyna, MD/PhD.

“Saisei Pharma is taking a number of steps to address the urgent need arising from the COVID-19 pandemic,” said Dr. Toshio Inui, MD, Head Global Drug Development and Chief Medical Officer. “The potential that oral MAF could lead to faster recovery for COVID-19 patients with fewer requiring intensive care and mechanical ventilation is encouraging and merits further investigation. While oral MAF is very safe, its safety and efficacy profile has not yet been established with regards to COVID-19.”

Given the global spread of the pandemic, and as plans for the study are being finalized, Saisei Pharma also has set up an international compassionate use program for eligible patients, subject to local approvals. In addition, steps are taken to manage the anticipated increase in COVID-19 related requests for oral MAF without interrupting access for patients taking oral MAF for its current indications. Saisei Pharma intends to join key industry partners against COVID-19 to complement the array of available therapy options. To support access, Saisei Pharma is committed to keeping stable prices for its range of products that may help in the treatment of COVID-19.

About Saisei Pharma oral MAF

Clinically active form of oral MAF is derived from enzyme-treated dairy products. MAF resulted from decades-long R&D activity by Saisei Pharma aimed at improving production technology and ensure the product’s higher activity and stability. The final goal is to make oral MAF available globally for conditions involving inadequate immune response due to macrophage dysfunction and hyper immune-inflammatory disorders in adult and pediatric patients. Saisei Pharma has filed a series of patents in Japan, EU, USA, and worldwide which relate to the technology, comprising the composition and method of production. Oral MAF is available as a health food or immunomodulating supplement in several countries, e.g., USA, Spain, Lithuania, and Ukraine. The exact indication for oral MAF varies by country. Additional worldwide regulatory filings are underway in other countries. Information about Saisei Pharma is available on the company website http://www.saisei-pharma.co.jp.

Saisei Pharma Global Media Relations

Contact: Mr. Martin Mette

Email: contact-sp@saisei-pharma.co.jp

Tel: +81-90-8823-0885

References

1. Sumiya Y, Ishikawa M, Inoue T, Inui T, Kuchiike D, Kubo K, Uto Y, Nishikata T. Macrophage activation mechanisms in human monocytic cell line-derived macrophages. Anticancer Res 2015;35:4447-51.

2. Ishikawa M, Mashiba R, Kawakatsu K, Tran NK, Nishikata T. (2018). A high-throughput quantitative assay system for macrophage phagocytic activity. Macrophage 2018;5:e1627.

3. Uto Y, Kawai T, Sasaki T, Hamada K, Yamada H, Kuchiike D, Kubo K, Inui T, Mette M, Tokunaga K, Hayakawa A, Go A, Oosaki T. Degalactosylated/desialylated bovine colostrum induces macrophage phagocytic activity independently of inflammatory cytokine production. Anticancer Res 2015;35:4487-92.

4. Mohamad SB, Hori H, Nagasawa H, Usui K, Uto Y. Characterization of human Gc protein-derived macrophage activation factor (GcMAF) and its functional role in macrophage tumoricidal activity. Adv Exp Med Biol. 2003;510:77‐82.

Disclaimer

This press release contains forward-looking statements regarding potential marketing approvals, new indications or labeling for oral MAF, regarding potential future revenues from such products, regarding our plans to initiate a clinical trial to evaluate the use of oral MAF in COVID-19 patients, or regarding the international compassionate use program for eligible patients. You should not place undue reliance on these statements. Such forward-looking statements are based on our current beliefs and expectations regarding future events and are subject to significant known and unknown risks and uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those set forth in the forward-looking statements. There is no guarantee that oral MAF will be submitted or approved for sale or for any additional indications or labeling in any market, or at any predetermined time. Neither can there be any guarantee that we will initiate the planned clinical trial in the expected time frame. Nor can there be any guarantee that oral MAF will meet the primary or secondary endpoints of the planned trial. Neither can there be any guarantee that oral MAF will be commercially successful in the future. Our expectations regarding Saisei products and the international compassionate use program could be affected by, among other things, the uncertainties inherent in research and development, including clinical trial results and additional analysis of existing clinical data; regulatory actions or delays or government regulation generally; global trends toward health care cost containment, including government, payor and general public pricing and reimbursement pressures and requirements for increased pricing transparency; our ability to obtain or maintain proprietary intellectual property protection; prescribing preferences of physicians and patients; general political, economic and business conditions, including the effects of and efforts to mitigate pandemic diseases such as COVID-19; safety, quality, data integrity or manufacturing issues; potential or actual data security and data privacy breaches, or disruptions of our information technology systems, and other risks and factors. Saisei Pharma is providing the information in this press release as of this date and does not undertake any obligation to update forward-looking statements contained in this press release as a result of new information, future events or otherwise.

Share article on social media or email:

LibertyUnites Answers George W. Bush’s Call To Be “Creative In Our Outreach”!


Liberty Unites Compassion To Heal Hearts Damaged By Coronavirus

Liberty Unites Compassion To Heal Hearts Broken By Coronavirus

“We serve our neighbor by separating from them, we cannot allow physical separation to become emotional isolation. This requires us to not only be compassionate but creative in our outreach.” – George W. Bush Jr

Globally, more than a quarter million people have died from coronavirus. As the death-toll from COVID-19 approaches 70,000 in the USA, a hidden gem of compassion online hosting over nine thousand tributes to the victims of war and terror founded on September 21st 2001 — LibertyUnites has opened its virtual doors with new features for vigils to victims of coronavirus and saluting the selfless heroes risking their lives to save us.

LibertyUnites.us is an advertising free website without any cost to members that host a vigil for friends or loved ones. LU offers a very user-friendly submission form to add a tribute profile including images with only email registration required. Guest visitors are not required to create an account to light a candle, post prayers, condolences or salute our front-line heroes.

According to John Coates, the website’s creator, “Its been LU’s goal for over 18 yrs to make it easy to put people’s names behind a staggering number of preventable deaths, put faces behind those names, than unite compassion and love from around the world under those faces”

Now that churches are closed, mass burials happen without funerals, grief without loving hugs and no gatherings of friends or family. LU offers a lasting dedicated place for online remembrance of loved ones lost to COVID along side the thousands of 911 victims, and those killed in the war on terror – whose loved-ones also never got to say goodbye.

LU was rebuilt with all these new features after, Coates had to self-isolate from family due to a slight fever and a very inflammatory rash which developed on his chest and shoulders. Unsure if the rash was from yard work, or a trip to the grocery store days before- protecting his family, Coates self-isolated.

Coates stressed, ”It was heartbreaking for my 2 year old daughter to cry for me on the other side of a door that I couldn’t open. She couldn’t understand why daddy couldn’t come out. This virus is ruthless in so many ways. One of the biggest is how it keeps those closest to one’s heart away as it robs them of their loved ones and air at the same time.

Coates felt there was more that could be done to remember, and pray for the victims that were kept away from their families through it all.

The websites creator got to work on LU’s database conversion to support populating all the front-line hospitals in the USA and UK, over 8 thousand of them.

Coates said, ”I pushed myself to get LibertyUnites done as fast as I could because I couldn’t help that it would cross my mind if I was going to be the first coronavirus vigil on the site or not. Thank God, the swelling under the rash near both shoulders went down a few days later, and the little bumps about 7 days after that.”

Coates feels really lucky and thanks God to have just had a scare.

Now it’s time for LU live out its purpose. For liberty to unite love, compassion, prayers and condolences from around the world.

We ask for your help at Liberty Unites to light a candle for every COVID 19 victim and salute every front-line hero!

LET US PRAY FOR THE STRENGTH AND KNOWLEDGE TO DEFEAT THE VIRUS!

“… just praying that you pray for me, I’ll pray for you, and we have to reach out to support each other during this time because we are going to get through this and we are going to shine brighter than ever, much love, from my heart to yours.” – Marla Maples on Instagram

LibertyUnites.us gives a special thank you to our sponsors LightSaver and RF Safe for server resources and scripts needed to make the new LU a reality!

Share article on social media or email: